Healthcare solutions company Evolent Health (NYSE:EVH) will be reporting results tomorrow after market close. Here’s what to expect. Evolent Health missed analysts’ revenue expectations by 1% ...
For the quarter ended December 2024, Evolent Health (EVH) reported revenue of $646.54 million, up 16.3% over the same period last year. EPS came in at -$0.02, compared to $0.23 in the year-ago ...
In a report released today, Matthew Gillmor CFA from KeyBanc maintained a Buy rating on Evolent Health (EVH – Research Report), with a price target of $20.00. The company’s shares closed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results